PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer

T. Fujita, H. Doihara, K. Kawasaki, D. Takabatake, H. Takahashi, K. Washio, K. Tsukuda, Y. Ogasawara, N. Shimizu

Research output: Contribution to journalArticlepeer-review

141 Citations (Scopus)

Fingerprint

Dive into the research topics of 'PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences